Clinical Trial Update: Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic interaction study evaluating Hemay005 tablets with midazolam (midazolam maleate tablets) in psoriasis patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Hemay005 Tablets
• Midazolam maleate tablets (midazolam)

Snippet

Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd | Conditions: Psoriasis | Phase 1 | Status: COMPLETED